a Predictive Scheme for Poor Responders in IVF Cycles

• Sponsor: Dina Mohamed Refaat Dakhly (Other)
• Overall Status: Completed
• CT.gov ID: NCT02351193
• Collaborator: (none)
• Enrollment: 928
• Location: 1
• Duration (Months): 35
• Patients Per Site Per Month: 26.5

Study Details

Study Description

Brief Summary

While practicing the different assisted reproductive techniques, the investigators are faced daily by the problem of poor responder females, and the debate about predicting its results based on the outcome of the different ORTs used. Due to the cost of AMH as an indicator for ovarian response, the need to re-assess its role was essential in our community, which led us to conduct this prospective multi-center IVF study.

Condition or Disease	Intervention/Treatment	Phase
Infertility	Other: transvaginal Ultrasound

Study Design

• Study Type: Observational
• Actual Enrollment: 928 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: A Predictive Scheme to Assess the Outcome of IVF/ICSI Cycles in Poor Responders. an Observational Study in Egypt
• Study Start Date: Jan 1, 2011
• Actual Primary Completion Date: Dec 1, 2013
• Actual Study Completion Date: Dec 1, 2013

Arms and Interventions

Arm	Intervention/Treatment
Group I poor responder females with age less than 35	Other: transvaginal Ultrasound
Group II poor responder females with age more than 35	Other: transvaginal Ultrasound

Outcome Measures

Primary Outcome Measures

1. Number of MII oocytes [2 years]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 20 Years to 45 Years
• Sexes Eligible for Study: Female
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• normal body mass index (BMI)

• AMH from 0.5-1.1 ng/ml.

• previous history of ≤3 oocytes retrieved using conventional long stimulation protocol

Exclusion Criteria:

• Females suffering from other causes of infertility as tubal, uterine factors or known cases of endometriosis

• severe cases of male factor as azospermia

• females who were unable or not willing to participate in the study were excluded from the study.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Kasr el aini hospital	Cairo		Egypt

Sponsors and Collaborators

• Dina Mohamed Refaat Dakhly

Investigators

• Principal Investigator: Dina MR Dakhly, MD, Cairo University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Dina Mohamed Refaat Dakhly, Lecturer of Obstetrics and Gynecology, Woman's Health University Hospital, Egypt
• ClinicalTrials.gov Identifier: NCT02351193
• Other Study ID Numbers: 26012015
• First Posted: Jan 30, 2015
• Last Update Posted: Feb 2, 2015
• Last Verified: Jan 1, 2015

• Additional relevant MeSH terms: Infertility

Study Results

No Results Posted as of Feb 2, 2015